Most cited papers from OWL (Spain)

OWL (Spain)

What are the most cited papers from OWL (Spain)?

The most cited paper from OWL (Spain) is "Angiotensin II induces contraction and proliferation of human hepatic stellate cells" (Ramon A. Bataller, Pere Ginès, Josep Maria Nicolás et al., 2000), with 495 citations. Next come "Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma" (293) and "Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression" (228).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 53 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Angiotensin II induces contraction and proliferation of human hepatic stellate cells Ramon A. Bataller, Pere Ginès, Josep Maria Nicolás et al. · Gastroenterology Open access	Jun 2000	495
2	Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma Ander Arbelaiz et al. · Hepatology Open access	26 May 2017	293
3	Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression James W. Barr et al. · Journal of Proteome Research Open access	24 Feb 2012	228
4	Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly Jorge Simón et al. · Cell Metabolism Open access	21 Feb 2020	148
5	Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis Maite Martinez‐Uña, Marta Varela‐Rey, Ainara Cano et al. · Hepatology Open access	16 Mar 2013	125
6	Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children Heike K. Hartter, Oluseyi I. Oyedele, Klaus Dietz et al. · The Pediatric Infectious Disease Journal	Jul 2000	115
7	The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease Divya P. Kumar, Rebecca Caffrey, Jonathon Marioneaux et al. · Scientific Reports Open access	9 Jun 2020	108
8	The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma Monika Lewińska et al. · EBioMedicine Open access	28 Oct 2021	85
9	Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF) Mazen Noureddin et al. · Hepatology Open access	24 Jul 2023	82
10	Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles Ibon Martínez‐Arranz et al. · Hepatology Open access	27 Feb 2022	65
11	Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice Martine C. Morrison, Lars Verschuren, Kanita Salic et al. · Hepatology Communications Open access	29 Oct 2018	58
12	Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study Joaquín Fernández‐Irigoyen, Paz Cartas‐Cejudo, Marta Iruarrizaga‐Lejarreta et al. · Biomedicines Open access	29 Apr 2021	57
13	Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy Nieves Embade, Zoe Mariñó, Tammo Diercks et al. · PLoS ONE Open access	9 May 2016	57
14	Acute liver injury associated with the use of ebrotidine, a new H 2 -receptor antagonist Raúl J. Andrade, M. Isabel Lucena, Rafael Martín-Vivaldi et al. · Journal of Hepatology	Oct 1999	56
15	Identification and experimental validation of druggable epigenetic targets in hepatoblastoma Alex Clavería-Cabello et al. · Journal of Hepatology Open access	10 Jun 2023	54
16	miR ‐21‐5p promotes NASH ‐related hepatocarcinogenesis Pedro Miguel Rodrigues, Marta B. Afonso, André Lopes Simão et al. · Liver International Open access	3 Aug 2023	50
17	Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus Fernando Bril, Laura Millán, Srilaxmi Kalavalapalli et al. · Diabetes Obesity and Metabolism	12 Mar 2018	50
18	Lagrangian observations in the Iberian coastal transition zone R. Haynes, Eric D. Barton · Journal of Geophysical Research Atmospheres Open access	15 Aug 1991	49
19	Randomised clinical trial: a leucine‐metformin‐sildenafil combination ( NS ‐0200) vs placebo in patients with non‐alcoholic fatty liver disease Naga Chalasani, Raj Vuppalanchi, Mary Eugenia Rinella et al. · Alimentary Pharmacology & Therapeutics Open access	25 Apr 2018	40
20	Solute Carrier Family 2 Member 1 Is Involved in the Development of Nonalcoholic Fatty Liver Disease Mercedes Vázquez–Chantada et al. · Hepatology Open access	7 Sep 2012	39
21	Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation Roberto Segovia, Alberto Sánchez‐Fueyo, Antoni Rimola et al. · Liver Transplantation	Feb 2001	36
22	Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Laura delaCruz‐Villar et al. · World Journal of Gastroenterology Open access	9 Sep 2020	33
23	Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients Manuel Crespo, Juan Ignacio Esteban, Esteban Ribera et al. · AIDS	12 Feb 2007	32
24	Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis María Mercado-Gómez et al. · International Journal of Molecular Sciences Open access	27 Nov 2020	30
25	Endogenous cortisol excess confers a unique lipid signature and metabolic network Arturo Vega‐Beyhart, Marta Iruarrizaga‐Lejarreta, Adriana Pané et al. · Journal of Molecular Medicine	21 Apr 2021	27
26	CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort Marta Herreros‐Villanueva, Lourdes Ruiz-Rebollo, Mario Montes et al. · Molecular Biology Reports	8 Jan 2020	23
27	The Metabolomic Profile of Spent Culture Media from Day-3 Human Embryos Cultured under Low Oxygen Tension María José de los Santos, Pilar Gámiz, J.M. De los Santos et al. · PLoS ONE Open access	12 Nov 2015	20
28	ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process Umberto Cillo et al. · Transplant International Open access	24 Oct 2022	18
29	One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population Paula Iruzubieta, Rebeca Mayo, Itziar Mincholé et al. · United European Gastroenterology Journal Open access	4 Aug 2024	16
30	European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation Marina Berenguer, Eléonora De Martin, Amelia Judith Hessheimer et al. · Transplant International Open access	30 Aug 2023	16
31	Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis Oana Nicoară-Farcău et al. · Hepatology	22 Feb 2023	12
32	Hepatic hemodynamics and transient elastography in alcoholic foamy degeneration: report of 2 cases Pablo Ruíz, Javier Michelena, José Trinidad Altamirano et al. · Annals of Hepatology Open access	May 2012	11
33	Classification of Common Food Lipid Sources Regarding Healthiness Using Advanced Lipidomics: A Four-Arm Crossover Study Milena Monfort‐Pires, Santosh Lamichhane, Cristina Alonso et al. · International Journal of Molecular Sciences Open access	3 Mar 2023	8
34	Intrahepatic Bleeding due to Undifferentiated (Embryonal) Hepatic Sarcoma Yanette Suárez, Antonio M. Lacy, Josep Maria Llovet · Journal of Hepatology Open access	Feb 2000	7
35	Lipidomics and biodistribution of extracellular vesicles‐secreted by hepatocytes from Zucker lean and fatty rats Maria Azparren‐Angulo, Justyna Mleczko, Oihane E. Albóniga et al. · Journal of Extracellular Biology Open access	Feb 2024	6
36	Evaluation of the Level of Knowledge of Infant and Primary School Teachers with Respect to the Attention Deficit Hyperactivity Disorder (ADHD): Content Validity of a Newly Created Questionnaire Marian Soroa, Nekane Balluerka, Arantxa Gorostiag · InTech eBooks Book chapterOpen access	15 Feb 2012	5
37	Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study Michael Pavlides et al. · Nature Medicine Open access231 authors	24 Jul 2026	4
38	Mass Spectrometry Applied to Human Cerebrospinal Fluid Lipidome Laura Millán, Joaquín Fernández‐Irigoyen, Enrique Santamaría et al. · Methods in molecular biology Book chapter	2019	4
39	Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): artificial intelligence in IBD surgery—opportunities and limitations Alaa El-Hussuna et al. · Journal of Crohn s and Colitis Open access	24 Jul 2025	3
40	Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models Ibon Martínez‐Arranz, Cristina Alonso, Rebeca Mayo et al. · Computer Methods and Programs in Biomedicine	26 Jul 2024	1
41	Plasma miRNAs signature validation for early detection of colorectal cancer Marta Herreros‐Villanueva, Saray Durán-Sanchón, Ágatha Martín et al. · Annals of Oncology Open access	Jun 2018	1
42	Mass Spectrometry Applied to Human Cerebrospinal Fluid Lipidome (II) Laura Millán, Joaquín Fernández‐Irigoyen, Enrique Santamaría et al. · Methods in molecular biology Book chapter	2025	0
43	The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients Kung-Hung Lin, Núria Amigó, Pablo Ortiz et al. · Clínica e Investigación en Arteriosclerosis (English Edition) Open access	2025	0
44	A baseline signature of metabolites involving the gut-liver axis predicts MRI-PDFF response to FASN inhibitor TVB-2640: results from the FASCINATE-1 study Rohit Seth Loomba, Marie O’Farrell, Eduardo Malheiros Correa Costa Martins et al. · Journal of Hepatology	Jul 2022	0
45	P-33 EVALUATION OF CIRCULATING METABOLOME IN THE SEARCH OF POTENTIAL DRUG-INDUCED LIVER INJURY BIOMARKERS Daniel Enrique Di Zeo-Sánchez, Inmaculada Medina‐Cáliz, Judith Sanabria‐Cabrera et al. · Annals of Hepatology Open access	Sep 2021	0
46	OR03-05 Novel Lipidome Signature in Active Cushing Syndrome Revealed by UHPLC-MS Metabolomics Arturo Vega‐Beyhart, Marta Iruarrizaga‐Lejarreta, Guillermo García-Eguren et al. · Journal of the Endocrine Society Open access	Apr 2020	0
47	Fatty Acid Compositions of Ceramides and Sphingomyelins in Mammalian Tissues and Cultured Cells Félix M. Goñi, Marco M. Manni, Jesús Sot et al. · Biophysical Journal Open access	Feb 2019	0
48	Translational strategy in NASH diversity: learning from mouse models Cristina Alonso, Marta Iruarrizaga‐Lejarreta, Laura Dela Cruz-Villar et al. · European Journal of Molecular & Clinical Medicine Open access	7 Sep 2017	0
49	Tracking the evolution of NAFLD through a non-invasive lipidomic test that accurately discriminates NASH from steatosis Cristina Alonso, Manel Garcia, Beatriz Antolín et al. · European Journal of Molecular & Clinical Medicine Open access	7 Sep 2017	0
50	379 QUANTITATIVE ASSESSMENT OF STEATOSIS IN LIVER TRANSPLANTATION BY MORPHOMETRIC ANALYSIS Maurizio Vertemati, Maria Goffredi, Paolo Aseni et al. · Journal of Hepatology Open access	Apr 2010	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.